CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

Making Digital Health a Primary Rather than an Additive Solution

Jennifer Briley Christian, Vice President, Clinical Evidence, IQVIA
Tweet

From mobile apps and wearables to smartphones and sensors, digital health is on the rise. Powerful technologies are capturing data continuously, monitoring patients remotely, relaying real-world insights at scale, and allowing us to reimagine evidence generation.


But how can researchers make the best use of these advances to reliably support data collection? There are many factors to consider in this fast-evolving landscape and very little guidance for decision-making.


In collaboration with the Agency for Healthcare Research and Quality (AHRQ), we’ve been exploring the opportunities for adopting digital health in registries. We’ve looked at mHealth, eHealth, social media and the Internet of Things to understand the current use of digital technologies, their strengths and limitations, their promising applications for the future, and how to determine their value.


A digital checklist for registries:


For researchers considering a digital approach, this work suggests the importance of hearing from patients, future proofing against technology obsolescence, and making digital health a primary rather than an additive solution. The process should start by asking the right questions to be certain that digital is a valid way forward.


1. What do we hope to accomplish? Identify the reason for incorporating digital health in the study.


2. How usable is the device or approach? Understand the likelihood of patient engagement and benefit, whether technical support is available if needed, and whether a plan is in place with the physician and patient for integration into registry operations.


3. Can we deal with the data? Determine the level of comfort with data provenance, the geographic implications for storage and analysis, and plans for how the data will be securely captured, stored and analyzed to meet relevant regulatory requirements.


4. Will the technology stand the test of time? Establish the availability of ‘open source’ vs. proprietary-only support, the risk of support being withdrawn, the technology’s maturity and the implications of updates, and the existence of standards for usage.


As the capabilities of digital health continue to expand, leaders are envisioning a healthcare landscape transformed by patient-generated data


As the capabilities of digital health continue to expand, leaders are envisioning a healthcare landscape transformed by patient-generated data. By investing now to develop the right skill sets and methodologies to leverage these technologies effectively, researchers can be ready to optimize the next decade of digital opportunities for data collection in registries.


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Value of New Antibiotics in the Fight Against AMR

Piero Rijli, Corporate Director, Regulatory Activities and Market Access, MENARINI Group

Improving Minimal Residual Disease Detection Using NGS

Steven Henck, Ph.D., Vice President of R&D, Integrated DNA Technologies

Multiomic Preclinical Models to Define the Mechanism of Action

Mitch Sanders, Chief Scientific Officer and EVP of the ProDevLab, at Alira Health

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Sanjay Konagurthu, Senior Director, PDS Global Science and Technology, Thermo Fisher Scientific

What the New EMA Draft "Guideline on Computerised Systems and Electronic Data" Means to Your Systems

Cathlin Shapiro, Director, Technology Quality Assurance, Parexel

Pharmaceutical Tablet Coating - Past, Present and Future

Steve Brown, Senior Director EU and APAC Global Manufacturing Science and Technology, Teva Pharmaceuticals [NYSE: TEVA]

Dynamic Commercial Aspects of Life Sciences

Jim Cooper, Director, Clinical Operations, Moderna

Achieving trial master file quality, timeliness and completeness

Susan K. Maue, Designation : Managing Director PharmaLex
Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/making-digital-health-a-primary-rather-than-an-additive-solution-nwid-60.html